EUVIMEDEUVIMED entdecken
Kohortenstudie

A Robust Multivariate Approach Unveils a 1 H-NMR-Based Spectral Metabolomics Signature Predictive of Cardiovascular Disease in People with Type 2 Diabetes: A Prospective Di@bet.es Cohort Study

Pere Rehues iD, Montse Guardiola iD, Núria Amigó iD, Gemma Rojo-Martínez iD, Roger Mallol-Parera iD, Josep Ribalta iD

Journal of Proteome Research · 05.12.2025 · 24 (12) · 6131-6141

DOI: 10.1021/acs.jproteome.5c00662 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Journal of Proteome Research, online erschienen am 19.11.2025. Verfasst von Pere Rehues und 5 weiteren Autor:innen. Beteiligte Einrichtung: Departament de Medicina i Cirurgia, Universitat Rovira i Virgili, Unitat de Recerca En Lípids i Arteriosclerosi, Reus 43201, Spain. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Metabolomics, Cardiovascular Diseases, Proton Magnetic Resonance Spectroscopy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 69 Literaturangaben. Gefördert von: Ministerio de Ciencia, Innovaci??n y Universidades, European Commission, Centres de Recerca de Catalunya.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

People with type 2 diabetes mellitus (T2DM) are at high risk of cardiovascular disease (CVD), which is often not explained by traditional risk factors such as low-density lipoprotein (LDL) cholesterol. Proton nuclear magnetic resonance (1H NMR) metabolomics is a promising tool to help explain this residual risk. This study aimed to evaluate the incidence of CVD in people with T2DM via untargeted 1H NMR data. The 1H NMR raw spectra of 24 cases and 24 controls (with basal T2DM and with/without CVD at follow-up) matched by age, sex, body mass index, and LDL cholesterol from the Di@bet.es cohort were processed, and the peak-picked features (p = 269) were used in a partial least-squares discriminant analysis classification with repeated double cross-validation and validated against permuted data sets (AUC = 0.758; p-value = 0.011). For each feature, a stringent variable selection method analyzing the distributions of variable importance in projection scores and beta coefficients across all the repeated models was used, yielding a metabolomic signature composed of 16 selected features related to inflammation, triglycerides, muscular function, and HDL particles, together with features putatively arising from albumin, although further validation of the annotations is needed. In summary, untargeted 1H NMR metabolomics can help assess cardiovascular risk in people with T2DM beyond LDL cholesterol.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2MetabolomicsCardiovascular DiseasesProton Magnetic Resonance SpectroscopyHumansMaleFemaleMiddle AgedProspective StudiesAgedMultivariate AnalysisCase-Control StudiesCholesterol, LDLRisk Factors

Stichwörter der Autor:innen

cardiovascular diseaselow molecular-weight metabolitesmetabolomicsmultivariate data analysisnuclear magnetic resonance spectroscopypartial least-squares discriminant analysistype 2 diabetes mellitus

Substanzen

Cholesterol, LDL

Autor:innen und Institutionen

  • Departament de Medicina i Cirurgia, Universitat Rovira i Virgili, Unitat de Recerca En Lípids i Arteriosclerosi, Reus 43201, Spain.
  • Institut d'Investigació Sanitària Pere Virgili, Reus 43204, Spain.
  • Centro de Investigación Biomédica En Red de Diabetes y Enfermedades Metabólicas Asociadas, Madrid 28029, Spain.
  • Biosfer Teslab, Reus 43206, Spain.
  • Departament de Ciències Mèdiques Bàsiques, Universitat Rovira i Virgili, Reus 43201, Spain.
  • Metabolomics Platform, Universitat Rovira i Virgili, Reus 43204, Spain.

ORCID-Profile: Pere Rehues, Montse Guardiola, Núria Amigó, Gemma Rojo-Martínez, Roger Mallol-Parera, Josep Ribalta

Förderung

  • Ministerio de Ciencia, Innovaci??n y Universidades
  • European Commission
  • Centres de Recerca de Catalunya
  • Ministerio de Econom??a y Competitividad
  • Centro de Investigaci??n Biom??dica en Red Diabetes y Enfermedades Metab??licas Asociadas

Zitieren

APA

Rehues, P., Guardiola, M., Amigó, N., Rojo-Martínez, G., Mallol-Parera, R., & Ribalta, J. (2025). A Robust Multivariate Approach Unveils a 1 H-NMR-Based Spectral Metabolomics Signature Predictive of Cardiovascular Disease in People with Type 2 Diabetes: A Prospective Di@bet.es Cohort Study. Journal of Proteome Research, 24(12), 6131-6141. https://doi.org/10.1021/acs.jproteome.5c00662

Vancouver

Rehues P, Guardiola M, Amigó N, Rojo-Martínez G, Mallol-Parera R, Ribalta J. A Robust Multivariate Approach Unveils a 1 H-NMR-Based Spectral Metabolomics Signature Predictive of Cardiovascular Disease in People with Type 2 Diabetes: A Prospective Di@bet.es Cohort Study. Journal of Proteome Research. 2025;24(12):6131-6141. doi:10.1021/acs.jproteome.5c00662

BibTeX
@article{Rehues2025,
  author = {Rehues, Pere and Guardiola, Montse and Amigó, Núria and Rojo-Martínez, Gemma and Mallol-Parera, Roger and Ribalta, Josep},
  title = {A Robust Multivariate Approach Unveils a 1 H-NMR-Based Spectral Metabolomics Signature Predictive of Cardiovascular Disease in People with Type 2 Diabetes: A Prospective Di@bet.es Cohort Study},
  journal = {Journal of Proteome Research},
  year = {2025},
  volume = {24},
  number = {12},
  pages = {6131--6141},
  doi = {10.1021/acs.jproteome.5c00662}
}
Kostenlos starten →